Chuck Royce's CNTA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 362,873 shares of Centessa Pharmaceuticals plc (CNTA) worth $9.08 M, representing 0.09% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in CNTA, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 115,486 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Centessa Pharmaceuticals plc (CNTA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Centessa Pharmaceuticals plc (CNTA) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +115,486 | Add 46.68% | 362,873 | $25.01 |
| Q3 2025 | +247,387 | New Buy | 247,387 | $24.25 |
Chuck Royce's Centessa Pharmaceuticals plc Investment FAQs
Chuck Royce first purchased Centessa Pharmaceuticals plc (CNTA) in Q3 2025, acquiring 247,387 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Centessa Pharmaceuticals plc (CNTA) for 2 quarters since Q3 2025.
Chuck Royce's largest addition to Centessa Pharmaceuticals plc (CNTA) was in Q3 2025, adding 247,387 shares worth $6 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 362,873 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $9.08 M.
As of the Q4 2025 filing, Centessa Pharmaceuticals plc (CNTA) represents approximately 0.09% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Centessa Pharmaceuticals plc (CNTA) was 362,873 shares, as reported at the end of Q4 2025.